Industry Payments to Doctors Tied to Nonrecommended, Low-Value Drug Use
FRIDAY, Oct. 27, 2023-- Industry payments to physicians are associated with nonrecommended and low-value drugs, according to a study published online Oct. 25 in The BMJ.Aaron P. Mitchell, M.D., M.P.H., from the Sloan Kettering Cancer Center in New...
Read more »